158 related articles for article (PubMed ID: 38674308)
1. Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases.
Ostojic J; Kozic D; Panjkovic M; Georgievski-Brkic B; Dragicevic D; Lovrenski A; Boban J
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674308
[No Abstract] [Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. N-Acetyl peak in MR spectra of intracranial metastatic mucinous adenocarcinomas.
Liu X; Germin BI; Zhong J; Ekholm S
Magn Reson Imaging; 2010 Nov; 28(9):1390-4. PubMed ID: 20797831
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
[TBL] [Abstract][Full Text] [Related]
6. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
7. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
[TBL] [Abstract][Full Text] [Related]
8. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
11. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
[TBL] [Abstract][Full Text] [Related]
12. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas.
Ankush A; Sardessai S
Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207
[TBL] [Abstract][Full Text] [Related]
13. Serial proton magnetic resonance spectroscopy in lesions of Balò concentric sclerosis.
Chen CJ
J Comput Assist Tomogr; 2001; 25(5):713-8. PubMed ID: 11584230
[TBL] [Abstract][Full Text] [Related]
14. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
15. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
16. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
17. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
18. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
19. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
[TBL] [Abstract][Full Text] [Related]
20. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.
Lai PH; Weng HH; Chen CY; Hsu SS; Ding S; Ko CW; Fu JH; Liang HL; Chen KH
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1511-8. PubMed ID: 18499784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]